To uncover the mechanisms underlying the aggravated poor prognosis drived by BCL2L13 downregulation in ccRCC and pRCC, the correlation between BCL2L13 and these genes were analyzed. The gene discussed is BCL2L13; the disease is nonpapillary renal cell carcinoma.